Cellnovo Group S.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
7,670.40
3,443.90
26,452.60
10,928.00
13,105.00
Total Accounts Receivable
973.40
1,812.10
2,243.60
1,641.00
3,494.00
Inventories
639.10
720.60
1,007.30
1,843.00
2,032.00
Other Current Assets
108.20
132.50
181.60
870.00
1,009.00
Total Current Assets
9,391.20
6,109.00
29,885.00
15,282.00
19,640.00
Net Property, Plant & Equipment
786.70
522.50
1,475.90
3,430.00
3,616.00
Total Investments and Advances
-
5.30
50.50
34.00
35.00
Intangible Assets
553.00
2,019.80
4,933.90
5,925.00
7,151.00
Total Assets
10,730.80
8,656.60
36,345.40
24,671.00
30,442.00
ST Debt & Current Portion LT Debt
6,028.80
-
-
1,201.00
1,652.00
Accounts Payable
760.50
1,562.30
2,025.50
2,323.00
2,013.00
Other Current Liabilities
336.80
591.00
1,026.60
857.00
1,190.00
Total Current Liabilities
7,126.10
2,153.30
3,052.20
4,381.00
4,855.00
Long-Term Debt
-
9,508.60
2,778.10
462.00
3,865.00
Provision for Risks & Charges
-
1.30
6.00
15.00
15.00
Total Liabilities
7,126.10
11,663.30
5,836.30
4,858.00
8,735.00
Common Equity (Total)
3,604.60
3,006.70
30,509.10
19,813.00
21,707.00
Total Shareholders' Equity
3,604.60
3,006.70
30,509.10
19,813.00
21,707.00
Total Equity
3,604.60
3,006.70
30,509.10
19,813.00
21,707.00
Liabilities & Shareholders' Equity
10,730.80
8,656.60
36,345.40
24,671.00
30,442.00

About Cellnovo Group

View Profile
Address
13, rue de Londres
Paris Ile-de-France 75009
France
Employees -
Website http://www.cellnovo.com
Updated 07/08/2019
Cellnovo Group SA is a medical technology company, which specializes in diabetes. The company develops and markets the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. Its products portfolio includes system, switch, pump therapy, and patient stories.